Cargando…
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
BACKGROUND: The presence of vascular invasion is associated with poor survival in advanced hepatocellular carcinoma (HCC). We compared the effectiveness of hepatic arterial infusion chemotherapy (HAIC) and immune checkpoint inhibitors (ICIs), alone or in combination, in patients with advanced HCC. M...
Autores principales: | Wu, Juei-Seng, Hong, Tzu-Chun, Wu, Hung-Tsung, Lin, Yih-Jyh, Chang, Ting-Tsung, Wang, Chung-Teng, Liu, Wen-Chun, Hsieh, Ming-Tsung, Wu, I-Chin, Chen, Po-Jun, Chen, Chiung-Yu, Lin, Sheng-Hsiang, Chuang, Chiao-Hsiung, Han, Meng-Zhi, Chen, Huang-Pin, Tsai, Hong-Ming, Kuo, Hsin-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186549/ https://www.ncbi.nlm.nih.gov/pubmed/37201085 http://dx.doi.org/10.21037/jgo-22-858 |
Ejemplares similares
-
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022) -
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
por: Tsai, Hong-Ming, et al.
Publicado: (2021) -
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
por: Chiang, Hsueh-Chien, et al.
Publicado: (2023) -
SUN-566 Metabolic Effects of Cross-Hormone Treatments in Transgender Individuals in Taiwan
por: Lin, Liang-Yu, et al.
Publicado: (2020) -
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study
por: Liou, Jyh-Ming, et al.
Publicado: (2015)